| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 5 2226-2236, Copyright © 1995 by American Association of Immunologists
ARTICLES |
RI Smith, MJ Coloma and SL Morrison
Department of Microbiology and Molecular Genetics, University of California, Los Angeles 90024.
The 18-amino acid carboxyl-terminal tailpiece from IgM (mutp) has now been added to the carboxyl-termini of IgG1, IgG2, IgG3, and IgG4 constant regions to produce recombinant IgM-like IgGs. Polymeric IgGs obtained by this approach possess up to six Fcs and 12 antigen- combining sites, greatly increasing the avidity of their interactions with other molecules. Not surprisingly, the C activity of normally active IgG1 and IgG3 and somewhat less active IgG2 Abs is shown to be dramatically enhanced upon polymerization. The multiple Fcs present in a single molecule apparently allow for more efficient interactions with the multiple C1q heads present in C1, the first component of the classical C cascade. An unexpected result however, is that IgG4, normally devoid of C activity, when polymerized in the same fashion directs C-mediated lysis of target cells almost as effectively as the other polymers. Interestingly though, IgG4mutp does not deplete C activity in a standard consumption assay using soluble Ag. The other gamma mutp isotypes are capable of depleting 100% of the serum lytic ability even in the absence of Ag, whereas IgG4mutp shows no evidence of activity in this assay under any of the conditions tested. Additionally, we show that, in contrast to monomeric IgG, polymeric IgGs bind with very high affinity to Fc gamma receptor II (Fc gamma RII), a low affinity receptor for wild-type antibodies; however, binding to Fc gamma Rl, the high affinity receptor, appears to be unaltered. Finally, the in vivo t1/2 of the gamma mutp proteins is decreased relative to wild-type IgG, apparently because of rapid clearance of the polymeric fraction.
This article has been cited by other articles:
|
|
 |
|
  M. Lukashev, D. LePage, C. Wilson, V. Bailly, E. Garber, A. Lukashin, A. Ngam-ek, W. Zeng, N. Allaire, S. Perrin, et al. Targeting the Lymphotoxin-{beta} Receptor with Agonist Antibodies as a Potential Cancer Therapy Cancer Res., October 1, 2006; 66(19): 9617 - 9624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miller, G. Meng, J. Liu, A. Hurst, V. Hsei, W.-L. Wong, R. Ekert, D. Lawrence, S. Sherwood, L. DeForge, et al. Design, Construction, and In Vitro Analyses of Multivalent Antibodies J. Immunol., May 1, 2003; 170(9): 4854 - 4861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Burns, E. J. Pishko, A. Preston, D. J. Maskell, and E. T. Harvill Role of Bordetella O Antigen in Respiratory Tract Infection Infect. Immun., January 1, 2003; 71(1): 86 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Braathen, V. Sorensen, P. Brandtzaeg, I. Sandlie, and F.-E. Johansen The Carboxyl-terminal Domains of IgA and IgM Direct Isotype-specific Polymerization and Interaction with the Polymeric Immunoglobulin Receptor J. Biol. Chem., November 1, 2002; 277(45): 42755 - 42762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oudin, M. T. Libyh, D. Goossens, X. Dervillez, F. Philbert, B. Reveil, F. Bougy, T. Tabary, P. Rouger, D. Klatzmann, et al. A Soluble Recombinant Multimeric Anti-Rh(D) Single-Chain Fv/CR1 Molecule Restores the Immune Complex Binding Ability of CR1-Deficient Erythrocytes J. Immunol., February 1, 2000; 164(3): 1505 - 1513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Sorensen, I. B. Rasmussen, V. Sundvold, T. E. Michaelsen, and I. Sandlie Structural requirements for incorporation of J chain into human IgM and IgA Int. Immunol., January 1, 2000; 12(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Yoo, M. J. Coloma, K. R. Trinh, T. Q. Nguyen, L.-U. C. Vuong, S. L. Morrison, and K. R. Chintalacharuvu Structural Requirements for Polymeric Immunoglobulin Assembly and Association with J Chain J. Biol. Chem., November 19, 1999; 274(47): 33771 - 33777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Sorensen, V. Sundvold, T. E. Michaelsen, and I. Sandlie Polymerization of IgA and IgM: Roles of Cys309/Cys414 and the Secretory Tailpiece J. Immunol., March 15, 1999; 162(6): 3448 - 3455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Isaacs, J. Greenwood, and H. Waldmann Therapy with Monoclonal Antibodies. II. The Contribution of Fc{gamma} Receptor Binding and the Influence of CH1 and CH3 Domains on In Vivo Effector Function J. Immunol., October 15, 1998; 161(8): 3862 - 3869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Libyh, D. Goossens, S. Oudin, N. Gupta, X. Dervillez, G. Juszczak, P. Cornillet, F. Bougy, B. Reveil, F. Philbert, et al. A Recombinant Human scFv Anti-Rh(D) Antibody With Multiple Valences Using a C-Terminal Fragment of C4-Binding Protein Blood, November 15, 1997; 90(10): 3978 - 3983. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
